reported that suppressor of cytokine signaling‐3 (SOCS3) promoted an increase in TLR5‐induced TNF‐α, disrupted intestinal epithelial barrier function, exacerbated the inflammatory process, and promoted CRC development. This evidence concerns the gene TLR5 and colorectal carcinoma.